论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
非肥胖阻塞性睡眠呼吸暂停患者非酒精性脂肪肝和肝纤维化的危险因素
Authors Lian N, Wu J, Wang B, Lin S, Huang J, Chen J, Lin Q
Received 8 September 2022
Accepted for publication 24 November 2022
Published 5 December 2022 Volume 2022:14 Pages 2143—2149
DOI https://doi.org/10.2147/NSS.S388203
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Sarah Appleton
Purpose: Liver injury in non-obese obstructive sleep apnea (OSA) patients has received much attention in recent years. This study aimed to investigate risk factors of nonalcoholic fatty liver disease (NAFLD) and liver fibrosis in non-obese patients with OSA.
Methods: A retrospective study was conducted in the Sleep Center of the First Affiliated Hospital of Fujian Medical University. All consecutive non-obese patients with suspected sleep apnea admitted to the center were enrolled. The clinical characteristics of patients with simple snoring and with different severity OSA were compared. Multivariate logistic regression models were used to analyze the risk factors of NAFLD and liver fibrosis.
Results: A total of 410 patients were enrolled. The levels of triglyceride, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increased with the aggravation of OSA (All p< 0.05). Among non-obese patients with OSA, 17 (5%) were diagnosed with liver fibrosis and 228 (65%) with NAFLD; Apnea-hyponea index (AHI) was an independent predictor for NAFLD and liver fibrosis [OR (95% CI): 1.02 (1.00– 1.03), 1.04 (1.00– 1.07), both p< 0.05]; hypertriglyceridemia was an independent predictor for NAFLD [OR (95% CI): 1.13 (1.12– 1.99), p< 0.05].
Conclusion: NAFLD and liver fibrosis were common in non-obese OSA patients and the severity of OSA was an independent risk factor for them.
Keywords: obstructive sleep apnea, non-alcoholic fatty liver disease, liver fibrosis